More Detail Needed On How Burnham’s Vision Will Be Made A Reality – The King’s Fund, UK

Responding to Secretary of State for Health Andy Burnham’s publication of NHS 2010-2015: from good to great: Preventative, people-centred, productive, The King’s Fund Director of Policy Dr Anna Dixon said:

Incidence Of Diabetes Likely To Double And Costs To Triple By 2034

In the next 25 years, the number of Americans living with diabetes will nearly double, increasing from 23.7 million in 2009 to 44.1 million in 2034. Over the same period, spending on diabetes will almost triple, rising from $113 billion to $336 billion, even with no increase in the prevalence of obesity, researchers based at [...]

Teva Provides Update On Generic Evista(R) Litigation

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA’s Orange Book for Eli Lilly’s Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva’s abbreviated new drug application to market a generic version. The court found these [...]

Diabetes UK Wants To Hear About Your Diabetes Experiences

Diabetes UK is looking for people with diabetes to share their experiences of supported self-management to help with our campaign for World Diabetes Day (14 November).
As 95 per cent of diabetes care is through self-management, this key issue is one of Diabetes UK’s priorities. It is about enabling people with diabetes to have the confidence [...]

Link Between Breast Cancer Hormone Receptor Status And Risk Of A Second Primary Tumor

Women with hormone receptor (HR) negative first tumors have twice as much risk for developing a second breast cancer as women with HR-positive tumors, according to a study published online July 9 in the Journal of the National Cancer Institute.